RecruitingNCT04278339
About this title
Study of Electrophysiological Markers Related to the Cognitive and Affective Processes Behind Empathic Behaviour in Schizophrenic Spectrum Disorder
Read the official source — NCT04278339Official study titleStudy of Electrophysiological Markers Related to the Cognitive and Affective Processes Behind Empathic Behaviour in Schizophrenic Spectrum Disorder
In NiceSchizophreniaInterventional studyAges 18–60
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Nice
RecruitingNCT06864065
About this title
Study of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder
Read the official source — NCT06864065Official study titleStudy of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder
Multiple locations, including BesançonEating disordersBehavioural studyAges 18–60
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Besancon
RecruitingNCT03100656
About this title
Study of Food Aversion in Patients With Anorexia Nervosa
Read the official source — NCT03100656Official study titleSolving EPHX2 and Polyunsaturated Fatty Acid Interactions in Anorexia Nervosa
Multiple locations, including La JollaEating disordersInterventional studyAges 18–55
- Countries
- United States, Canada
- Sponsor
- University of California, San Diego
RecruitingNCT06484387
About this title
Study of Intra- and Interpersonal Multimodal Synchronizations in a Social Interaction in Individuals with a Diagnosis of Schizophrenia.
Read the official source — NCT06484387Official study titleStudy of Multimodal Intra- and Interpersonal Synchronizations in Social Interaction in Individuals with a Diagnosis of Schizophrenia.
In MontpellierSchizophreniaBehavioural studyAges 18–60
- Countries
- France
- Sponsor
- University Hospital, Montpellier
RecruitingNCT06480383
About this title
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Read the official source — NCT06480383Official study titleA Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder Who Have an Inadequate Response to Generalized Anxiety Disorder Treatment
Multiple locations, including GlendaleAnxietyMedication study
- Countries
- United States, Bulgaria, Czechia, + 2 others
- Sponsor
- Intra-Cellular Therapies, Inc.
RecruitingNCT06701903
About this title
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Read the official source — NCT06701903What is this study about?Researchers are comparing ITI-1284 10 mg, ITI-1284 20 mg and placebo to find out how the approaches affect anxiety symptoms in people with an anxiety condition.
Multiple locations, including BirminghamAnxietyMedication studyAges 18+
- Countries
- United States, Bulgaria, Poland, + 2 others
- Sponsor
- Intra-Cellular Therapies, Inc.
RecruitingNCT06036316
About this title
Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psychosis
Read the official source — NCT06036316Official study titleStudy of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psychosis
In LaxouSchizophreniaBehavioural studyAges 16–55
- Countries
- France
- Sponsor
- Centre Psychothérapique de Nancy
RecruitingNCT05850689
About this title
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Read the official source — NCT05850689What is this study about?This study evaluates the safety and effectiveness of Lumateperone for people with depression.
Multiple locations, including HuntsvilleDepressionMedication studyAges 18–65
- Countries
- United States, France, Bulgaria, + 4 others
- Sponsor
- Intra-Cellular Therapies, Inc.
RecruitingNCT00018057
Official study titleStudy of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
Multiple locations, including BethesdaDepression, AnxietyMedication studyAges 8–65
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)
RecruitingNCT07520292
Official study titleThe Effects of NTX-2001, a Novel TAAR1 Partial Agonist, on Alcohol Consumption in Adults With Alcohol Use Disorder: A Phase 1b, Randomized, Placebo-Controlled, Proof-of-Concept Study
In New HavenAddictionMedication studyAges 21–60
- Countries
- United States
- Sponsor
- Newleos Therapeutics, Inc.
RecruitingNCT06399263
About this title
Study of Psilocybin for Anorexia in Young Adults
Read the official source — NCT06399263Official study titleStudy of Psilocybin for Anorexia in Young Adults
In San FranciscoEating disordersMedication studyAges 18–25
- Countries
- United States
- Sponsor
- Marissa Raymond-Flesch, MD, MPH
RecruitingNCT04945278
About this title
Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability
Read the official source — NCT04945278Official study titleStudy of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability (ALTER EGO)
In BoharsSchizophreniaInterventional studyAges 15–25
- Countries
- France
- Sponsor
- University Hospital, Brest